Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

Recall of Plasma Protein Fraction, Plasmanate-Talecris Biotherapeutics


October 11, 2005


Plasma Protein Fraction (Human) 5% USP, Plasmanate
26N39N1 9/20/2008


Talecris Biotherapeutics
Clayton, North Carolina


Talecris Biotherapeutics, Inc. (formerly Bayer Corporation), is initiating a voluntary recall of one lot of Plasmanate, Plasma Protein Fraction (Human) 5% USP. A portion of lot 26N39N1 was processed during a period of time when the equipment used to secure an overseal on the bottle was noted to have fallen out of proper adjustment. Consignees are asked to return existing stock to Talecris Biotherapeutics.

Contact FDA

(800) 835-4709
(240) 402-8010
Consumer Affairs Branch (CBER)

Division of Communication and Consumer Affairs

Office of Communication, Outreach and Development

Food and Drug Administration

10903 New Hampshire Avenue

Building 71 Room 3103

Silver Spring, MD 20993-0002

Page Last Updated: 06/26/2013
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English